Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine

被引:43
作者
Loomis, Rebecca J. [1 ]
DiPiazza, Anthony T. [1 ]
Falcone, Samantha [2 ]
Ruckwardt, Tracy J. [1 ]
Morabito, Kaitlyn M. [1 ]
Abiona, Olubukola M. [1 ]
Chang, Lauren A. [1 ]
Caringal, Ria T. [3 ]
Presnyak, Vladimir [2 ]
Narayanan, Elisabeth [2 ]
Tsybovsky, Yaroslav [4 ]
Nair, Deepika [1 ]
Hutchinson, Geoffrey B. [1 ]
Stewart-Jones, Guillaume B. E. [5 ]
Kueltzo, Lisa A.
Himansu, Sunny [2 ]
Mascola, John R. [5 ]
Carfi, Andrea [2 ]
Graham, Barney S. [1 ]
机构
[1] NIAID, Natl Inst Hlth, Viral Pathogenesis Lab, Vaccine Res Ctr, Bethesda, MD 20892 USA
[2] Moderna Inc, Cambridge, MA USA
[3] NIAID, Natl Inst Hlth, Vaccine Res Ctr, Vaccine Prod Program, Bethesda, MD 20892 USA
[4] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Vaccine Res Ctr Elect Microscopy Unit, Canc Res Technol Program, Frederick, MD USA
[5] NIAID, Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Vaccine Res Ctr,Virol Lab, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Nipah virus (NiV); mRNA; vaccine; Pre-F; G; structure-based immunogen design; pandemic preparedness and response; T cell responses; CRYO-EM STRUCTURE; HENDRA-VIRUS; HENIPAVIRUS INFECTION; MEMBRANE-FUSION; ANIMAL-MODELS; PIG-FARMERS; TRANSMISSION; ENCEPHALITIS; RECEPTOR; OUTBREAK;
D O I
10.3389/fimmu.2021.772864
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nipah virus (NiV) represents a significant pandemic threat with zoonotic transmission from bats-to-humans with almost annual regional outbreaks characterized by documented human-to-human transmission and high fatality rates. Currently, no vaccine against NiV has been approved. Structure-based design and protein engineering principles were applied to stabilize the fusion (F) protein in its prefusion trimeric conformation (pre-F) to improve expression and increase immunogenicity. We covalently linked the stabilized pre-F through trimerization domains at the C-terminus to three attachment protein (G) monomers, forming a chimeric design. These studies detailed here focus on mRNA delivery of NiV immunogens in mice, assessment of mRNA immunogen-specific design elements and their effects on humoral and cellular immunogenicity. The pre-F/G chimera elicited a strong neutralizing antibody response and a superior NiV-specific Tfh and other effector T cell response compared to G alone across both the mRNA and protein platforms. These findings enabled final candidate selection of pre-F/G Fd for clinical development.
引用
收藏
页数:14
相关论文
共 100 条
[1]  
Abdullah S, 2014, HAND CLINIC, V123, P663, DOI 10.1016/B978-0-444-53488-0.00032-8
[2]   Isolation and molecular identification of Nipah virus from pigs [J].
AbuBakar, S ;
Chang, LY ;
Ali, ARM ;
Sharifah, SH ;
Yusoff, K ;
Zamrod, Z .
EMERGING INFECTIOUS DISEASES, 2004, 10 (12) :2228-2230
[3]   Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].
Anderson, E. J. ;
Rouphael, N. G. ;
Widge, A. T. ;
Jackson, L. A. ;
Roberts, P. C. ;
Makhene, M. ;
Chappell, J. D. ;
Denison, M. R. ;
Stevens, L. J. ;
Pruijssers, A. J. ;
McDermott, A. B. ;
Flach, B. ;
Lin, B. C. ;
Doria-Rose, N. A. ;
O'Dell, S. ;
Schmidt, S. D. ;
Corbett, K. S. ;
Swanson, P. A., II ;
Padilla, M. ;
Neuzil, K. M. ;
Bennett, H. ;
Leav, B. ;
Makowski, M. ;
Albert, J. ;
Cross, K. ;
Edara, V. V. ;
Floyd, K. ;
Suthar, M. S. ;
Martinez, D. R. ;
Baric, R. ;
Buchanan, W. ;
Luke, C. J. ;
Phadke, V. K. ;
Rostad, C. A. ;
Ledgerwood, J. E. ;
Graham, B. S. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438
[4]   Nipah Virus Infection [J].
Ang, Brenda S. P. ;
Lim, Tchoyoson C. C. ;
Wang, Linfa .
JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (06)
[5]   Genomic Characterization of Nipah Virus, West Bengal, India [J].
Arankalle, Vidya A. ;
Bandyopadhyay, Bhaswati T. ;
Ramdasi, Ashwini Y. ;
Jadi, Ramesh ;
Patil, Dilip R. ;
Rahman, Mehebubar ;
Majumdar, Monalisa ;
Banerjee, Parthasarthi S. ;
Hati, Amiyakumar K. ;
Goswami, Ramaprasad P. ;
Neogi, Dhruba Kumar ;
Mishra, Akhilesh C. .
EMERGING INFECTIOUS DISEASES, 2011, 17 (05) :907-909
[6]   Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of Infection [J].
Arunkumar, Govindakarnavar ;
Devadiga, Santhosha ;
McElroy, Anita K. ;
Prabhu, Suresh ;
Sheik, Shahin ;
Abdulmajeed, Jazeel ;
Robin, Sudandiradas ;
Sushama, Aswathyraj ;
Jayaram, Anup ;
Nittur, Sudheesh ;
Shakir, Mohammed ;
Kumar, Keeriyatt Govindan Sajeeth ;
Radhakrishnan, Chandni ;
Sakeena, Karayil ;
Vasudevan, Jayasree ;
Reena, Kalathil Joseph ;
Sarita, Ragini Lohithakshan ;
Klena, John D. ;
Spiropoulou, Christina F. ;
Laserson, Kayla F. ;
Nichol, Stuart T. .
CLINICAL INFECTIOUS DISEASES, 2019, 69 (10) :1752-1756
[7]   Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018 [J].
Arunkumar, Govindakarnavar ;
Chandni, Radhakrishnan ;
Mourya, Devendra T. ;
Singh, Sujeet K. ;
Sadanandan, Rajeev ;
Sudan, Preeti ;
Bhargava, Balram ;
Gangakhedkar, Raman R. ;
Gupta, Nivedita ;
Bhargava, Balram ;
Mourya, D. T. ;
Yadav, Pragya D. ;
Shete, Anita M. ;
Sahay, Reema ;
Sudeep, A. ;
Bharadwaj, Sumit ;
Sugunan, A. P. ;
Manickam, P. ;
Bhatnagar, Tarun ;
Murhekar, Manoj ;
Arunkumar, Govindakarnavar ;
Abdulmajeed, Jazeel ;
Aswathyraj, Sushama ;
Santhosha, Devadiga ;
Anup, Jayaram ;
Sudheesh, Nittur ;
Anitha, Jagdesh ;
Robin, S. ;
Sabeena, Sasidharanpillai ;
Shakir, Muhammed ;
Sarthak, Pattanaik ;
Suresh, Prabhu ;
Maity, Hindol ;
Sheik, Shahin ;
Shilpa, C. ;
Karunakaran, Kavitha ;
Anjali, Aithal ;
Kumar, Sanjeeva ;
Venkatesh, Srinivasan ;
Ravindran, P. ;
Singh, Sujeet Kumar ;
Gupta, Naveen ;
Kulkarni, Sanket ;
Raghu, K. ;
Ali, M. K. Showkath ;
Jain, Ruchi ;
Chandra, Ramesh ;
Kiran, Jai ;
Khasnobis, Pradeep ;
Jain, S. K. .
JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (12) :1867-1878
[8]   A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex [J].
Avanzato, Victoria A. ;
Oguntuyo, Kasopefoluwa Y. ;
Escalera-Zamudio, Marina ;
Gutierrez, Bernardo ;
Golden, Michael ;
Pond, Sergei L. Kosakovsky ;
Pryce, Rhys ;
Walter, Thomas S. ;
Seow, Jeffrey ;
Doores, Katie J. ;
Pybus, Oliver G. ;
Munster, Vincent J. ;
Lee, Benhur ;
Bowden, Thomas A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (50) :25057-25067
[9]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[10]   Nipah virus disease: A rare and intractable disease [J].
Banerjee, Sayantan ;
Gupta, Nitin ;
Kodan, Parul ;
Mittal, Ankit ;
Ray, Yogiraj ;
Nischal, Neeraj ;
Soneja, Manish ;
Biswas, Ashutosh ;
Wig, Naveet .
INTRACTABLE & RARE DISEASES RESEARCH, 2019, 8 (01) :1-8